PharmaCorp Files 2024 Year End Audited Financial Statements and MD&A

Group 1 - PharmaCorp Rx Inc. has filed its audited financial statements and associated MD&A for the year ended December 31, 2024, on SEDAR+ [1] - The company operates three PharmaChoice bannered pharmacies in Canada and plans to acquire more as they become available [2] - PharmaCorp intends to acquire independently owned non-PharmaChoice Canada bannered pharmacies and operate them under the PharmaChoice Canada banner [2] Group 2 - PharmaCorp shares are traded on the TSX Venture Exchange under the symbol PCRX [2]